Contemporary Management of Secondary Mitral Regurgitation-Reference-Cited by-同舟云学术

Contemporary Management of Secondary Mitral Regurgitation

Published:2020-05-12 Issue: Volume:15 Page:
ISSN:1758-3764
Container-title:European Cardiology Review
language:en
Short-container-title:Eur Cardiol

Author:

Goel Kashish¹,Barker Colin M¹,Lindenfeld JoAnn¹

Affiliation:

1. Vanderbilt Heart and Vascular Institute, Vanderbilt University School of Medicine, Nashville, TN, US

Abstract

Secondary mitral regurgitation (SMR) is a common occurrence in patients with heart failure with reduced ejection fraction. Moderate-severe or severe SMR is associated with increased mortality and hospitalisations from heart failure. Medical and cardiac resynchronisation therapies have been the only treatments proven to improve prognosis in this patient population. The Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy (COAPT) and the Percutaneous Repair with the MitraClip Device for Severe Functional/Secondary Mitral Regurgitation (MITRA-FR) RCTs evaluated transcatheter mitral valve repair with MitraClip for treatment of SMR in addition to medical therapy and they had divergent results. The COAPT trial demonstrated that a reduction in SMR with MitraClip resulted in reduced mortality and heart failure hospitalisations along with improved symptoms and quality of life in appropriately selected patients. The MITRA-FR trial did not show any benefit from using MitraClip for patients with SMR. This article summarises the differences in these two trials and suggests a contemporary approach to the management of SMR.

Publisher

Radcliffe Group Ltd

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics – 2019 update: a report from the American Heart Association. Circulation 2019;139:e56–528. https://doi.org/10.1161/CIR.0000000000000659; PMID: 30700139.

2. de Marchena E, Badiye A, Robalino G, et al. Respective prevalence of the different carpentier classes of mitral regurgitation: a stepping stone for future therapeutic research and development. J Card Surg 2011;26:385–92. https://doi.org/10.1111/j.1540-8191.2011.01274.x; PMID: 21793928.

3. Sannino A, Smith RL, Schiattarella GG, et al. Survival and cardiovascular outcomes of patients with secondary mitral regurgitation: a systematic review and meta-analysis. JAMA Cardiol 2017;2:1130–9. https://doi.org/10.1001/jamacardio.2017.2976; PMID: 28877291.

4. Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2017;30:303–71. https://doi.org/10.1016/j.echo.2017.01.007; PMID: 28314623.

5. Nasser R, Van Assche L, Vorlat A, et al. Evolution of functional mitral regurgitation and prognosis in medically managed heart failure patients with reduced ejection fraction. JACC Heart Fail 2017;5:652–9. https://doi.org/10.1016/j.jchf.2017.06.015; PMID: 28859754.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Konservative Therapie von Herzklappenvitien im Erwachsenenalter;Die Innere Medizin;2024-03-04

2. Trends in Isolated Mitral Valve Repair or Replacement Surgery in Australia: A Statewide Cohort Linkage Study;Heart, Lung and Circulation;2023-12

3. All-Cause Mortality in Ischemic Heart Failure Patients with Functional Mitral Regurgitation Undergoing Percutaneous Coronary Intervention;The American Journal of Cardiology;2022-05

4. The role of surgery for secondary mitral regurgitation and heart failure in the era of transcatheter mitral valve therapies;Reviews in Cardiovascular Medicine;2022-03-04

5. Surgery for heart failure: Treatment options and implications;Journal of Cardiac Surgery;2021-02